AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.